Rubedo Life Sciences
Sunnyvale, United States · Founded 2018 · $52.0M raised
- Headquarters
- Sunnyvale, California
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- rubedolife.com
- Total Funding
- $52.0M
- Last Round
- $40.0M Series AApr 2024
- Rounds
- 2
About
Clinical-stage biopharma developing therapies that target senescent/pathologic cells to treat age-related diseases.
Summary
Rubedo Life Sciences is a Biotech company based in Sunnyvale, United States, founded in 2018. It has raised $52.0M in total across 2 rounds, most recently a $40.0M Series A round in Apr 2024. Investors include Khosla Ventures, Ahren Innovation Capital and LongeVC.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.